Page last updated: 2024-09-05

ro 32-3555 and Arthritis, Rheumatoid

ro 32-3555 has been researched along with Arthritis, Rheumatoid in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aitken, M; Durston, S; Harris, S; McClelland, GR; Sharp, S; Wood, ND	1
Banken, L; Farhan, M; Hemmings, FJ; Jain, R; Rowland, J	1

Trials

1 trial(s) available for ro 32-3555 and Arthritis, Rheumatoid

Article	Year
Tolerability and pharmacokinetics of the collagenase-selective inhibitor Trocade in patients with rheumatoid arthritis. Rheumatology (Oxford, England), 2001, Volume: 40, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Animals; Area Under Curve; Arthritis, Rheumatoid; Clinical Chemistry Tests; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hematologic Tests; Humans; Imidazoles; Joints; Male; Middle Aged; Protease Inhibitors; Rats; Species Specificity; Treatment Outcome	2001

Article

Year

Tolerability and pharmacokinetics of the collagenase-selective inhibitor Trocade in patients with rheumatoid arthritis.

Rheumatology (Oxford, England), 2001, Volume: 40, Issue:5

Topics: Adult; Aged; Aged, 80 and over; Animals; Area Under Curve; Arthritis, Rheumatoid; Clinical Chemistry Tests; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hematologic Tests; Humans; Imidazoles; Joints; Male; Middle Aged; Protease Inhibitors; Rats; Species Specificity; Treatment Outcome

2001

Other Studies

1 other study(ies) available for ro 32-3555 and Arthritis, Rheumatoid

Article	Year
Cartilage protective agent (CPA) Ro 32-3555, a new matrix metalloproteinase inhibitor for the treatment of rheumatoid arthritis. Agents and actions. Supplements, 1998, Volume: 49 Topics: Adult; Arthritis, Rheumatoid; Humans; Imidazoles; Male; Metalloendopeptidases; Middle Aged; Protease Inhibitors	1998